2m 2m 2m 2m 2m 2m 2m
- $3.6BMarket Cap
- -60.41%1-Year Change
- Health Information ServicesIndustry
DOXIMITY-A (DOCS)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 32
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Rosen Law Firm reminds investors who purchased Doximity Inc. (DOCS) shares between August 8, 2024 and May 13, 2026 of the November 16, 2026 deadline to file a securities class action lawsuit. The lawsuit alleges that Doximity misrepresented the impact of its news feed on revenue growth while losing market share to competitors with better pricing and user engagement models.
10/01/2026, 12:16 AM • GlobeNewswire
Rosen Law Firm has filed securities class action lawsuits against Doximity, Inc., Qfin Holdings, Inc., and Beta Bionics, Inc., alleging investor damages. The primary case detailed involves Doximity, which allegedly overstated its Newsfeed's revenue impact and lost market share to competitors. Investors have until November 16, 2026 to serve as lead plaintiff.
09/30/2026, 9:34 PM • GlobeNewswire
Rosen Law Firm is reminding investors in Doximity, DNOW Inc., and XTI Aerospace of upcoming deadlines to join securities class action lawsuits. The firm is seeking lead plaintiffs for cases alleging various corporate misconduct including revenue overstatement and market share losses.
09/27/2026, 6:38 PM • GlobeNewswire
Rosen Law Firm has filed securities class action lawsuits against DNOW Inc., Doximity Inc., and XTI Aerospace Inc., alleging false and misleading statements. The firm is seeking lead plaintiffs with an October 2, 2026 deadline for DNOW. Investors who held shares during specified periods may be eligible for compensation.
09/27/2026, 6:10 PM • GlobeNewswire
The Law Offices of Frank R. Cruz has announced class action lawsuits against four publicly-traded companies for allegedly making materially false and misleading statements to investors. Baidu faces allegations of overstating its AI business capabilities, Doximity of misrepresenting its Newsfeed's revenue impact, Better Home & Finance of concealing conversion funnel slowdowns, and Honeywell Aerospace of failing to disclose supplier constraints and cybersecurity investigation issues. Lead plaintiff deadlines range from November 13-23, 2026.
09/25/2026, 12:07 PM • GlobeNewswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
A class action lawsuit has been filed against Doximity, Inc. (NYSE: DOCS) for alleged violations of securities laws. The complaint alleges the company made false and misleading statements regarding its Newsfeed product's impact on revenue growth, overstated market position amid competitive pricing pressures, and misrepresented its advertising delivery methods. The class period spans August 8, 2024 to May 13, 2026, with a deadline of November 16, 2026 for investors to participate.
09/25/2026, 10:47 AM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Doximity, Inc., Honeywell Aerospace Inc., and UWM Holdings Corporation on behalf of investors who purchased securities during specified periods. The lawsuit against Doximity alleges the company overstated Newsfeed revenue impact and lost market share to competitors. Investors are encouraged to secure counsel before the November 16, 2026 deadline to serve as lead plaintiff.
09/24/2026, 8:45 PM • GlobeNewswire
Grabar Law Office announced investigations into potential breaches of fiduciary duties by officers and directors at Doximity, GoDaddy, Planet Fitness, and PROCEPT BioRobotics. The investigations follow federal securities class action filings alleging misleading statements regarding business metrics, pricing strategies, and financial guidance. Long-term shareholders meeting specific holding periods are eligible to seek corporate reforms and potential compensation at no cost.
09/24/2026, 9:36 AM • GlobeNewswire
Wolf Haldenstein has filed class action lawsuits against Doximity, Papa John's International, and Hims & Hers Health on behalf of shareholders who suffered losses. The lawsuits allege that these companies made false or misleading statements regarding their financial performance and business prospects. Doximity's stock declined significantly following multiple guidance misses and revenue warnings between November 2025 and May 2026.
09/23/2026, 5:54 PM • GlobeNewswire
Pomerantz Law Firm has filed a class action lawsuit against Doximity, Inc. for alleged securities fraud following three significant stock price declines in late 2025 and mid-2026. The company faced investor losses after issuing cautious guidance despite strong quarterly results, subsequently lowering revenue guidance and missing projections. The firm is also investigating claims against FuelCell Energy and Jackson Financial.
09/22/2026, 7:59 PM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Doximity, Inc., PROCEPT BioRobotics Corporation, and DNOW Inc. on behalf of investors who suffered losses. The Doximity lawsuit alleges the company overstated its Newsfeed's revenue impact and lost market share to competitors. Investors with losses exceeding $100,000 are encouraged to seek counsel before upcoming deadlines.
09/18/2026, 10:38 PM • GlobeNewswire
Rosen Law Firm reminds investors in DNOW Inc., PROCEPT BioRobotics Corporation, and Doximity Inc. of upcoming deadlines to join securities class action lawsuits. DNOW faces allegations of false statements regarding merger challenges with MRC Global, while similar class actions have been filed against the other companies. Investors must act by specified deadlines to potentially recover damages.
09/18/2026, 10:28 PM • GlobeNewswire
Rosen Law Firm has filed securities class action lawsuits against Wix.com Ltd., PROCEPT BioRobotics Corporation, and Doximity, Inc. The lawsuits allege that defendants made false and misleading statements regarding product performance, costs, and financial benefits. Investors who purchased securities during specified class periods are encouraged to secure counsel before the September 22, 2026 deadline to potentially join the litigation.
09/18/2026, 10:06 PM • GlobeNewswire
Why GitLab Stock Soared 35% in August and Why It's Already Rocketed Higher
GitLab stock surged 34.9% in August as investor fears about AI making software obsolete ('SaaSpocalypse') proved overblown. Multiple analysts raised price targets, recognizing that AI would complement rather than replace complex enterprise software. GitLab's Q2 fiscal 2027 results exceeded expectations with 21% YoY revenue growth and strong forward guidance, validating the market's renewed optimism.
09/06/2026, 3:03 AM • The Motley Fool
What Investors Should Know of This Doximity Officer's Latest Insider Transaction
Doximity's Chief Accounting Officer Siddharth Sitaram sold 5,652 shares worth $140,400 in mid-August. The transaction was driven by routine tax obligations from option exercises and restricted stock unit vesting rather than a loss of confidence in the company. Sitaram retains significant equity holdings of 93,122 shares. The sale reflects standard tax-driven liquidity management common among executives.
08/18/2026, 6:31 AM • The Motley Fool
Peers
Statistics
MoreInformation as of 10/01/2026
Company Profile
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Key Executives
- Jeffrey A. Tangney
- Siddharth Sitaram
- John Vaughan
- Steven L. Zatz
- Matthew Sonefeldt
Current Ownership Distribution
- Institutions2.0B (73.30%)
- Mutual Funds692.3M (24.85%)
- Insiders51.4M (1.84%)
- Other0 (0.00%)